
|Webinars|February 8, 2021
The Role and Rationale for Oral Options in the Treatment of Metastatic Breast Cancer
Breast cancer oncologists explore more recent advances using oral chemotherapies to treat metastatic breast cancer.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers
2
Patients Face New Care Complexities as DTC Options Expand
3
FDA Approves Gene Therapy Onasemnogene Abeparvovec for Broader SMA Population
4
FDA Approves Durvalumab With FLOT Chemotherapy for Resectable Gastric and Gastroesophageal Junction Cancer
5












































